Intracel starts Phase III bladder cancer study

Intracel (Rockville, Md.) began U.S. Phase III testing of its Keyhole Limpet Hemocyanin (KLH) immune stimulator and neo-antigen in 150 patients with refractory bladder cancer. The study will compare K...